The role of thyroid hormone nuclear receptors in the heart: Evidence from pharmacological approaches

Heart Failure Reviews

Volumn 15, Issue 2, 2010, Pages 121-124

  Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Alpha MHC; Amiodarone; Beta MHC; Dronedarone; Heart rate; Hypothyroidism; SERCA2a; Thyroid hormone receptor alpha 1; Thyroid hormone receptor beta 1

Indexed keywords

AMIODARONE; DEBUTYLDRONEDARONE; DRONEDARONE; ION CHANNEL; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA1; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; UNCLASSIFIED DRUG; ANTIARRHYTHMIC AGENT; MYOSIN HEAVY CHAIN; THYROID HORMONE RECEPTOR;

DRUG EFFECT; GENE EXPRESSION; HEART; HEART RATE; HORMONE RECEPTOR INTERACTION; HYPOTHYROIDISM; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; ANIMAL; CHEMICALLY INDUCED DISORDER; HUMAN; METABOLISM; PATHOPHYSIOLOGY;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; HEART; HEART RATE; HUMANS; HYPOTHYROIDISM; MYOSIN HEAVY CHAINS; RECEPTORS, THYROID HORMONE; TRIIODOTHYRONINE;

EID: 77953236309     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-008-9131-9     Document Type: Review

References (28)

1. Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116:1725-1735. doi:10.1161/CIRCULATIONAHA.106.678326
2. Singh BN, Vaughan Williams EM (1970) The effect of amiodarone, a new anti-anginal drug on cardiac muscle. Br J Pharmacol 39:657-667
3. Wiersinga WM, Trip MD, Van Beeren MH, Plomp TA, Oosting H (1991) An increase in plasma cholesterol independent of thyroid function during long-term amiodarone therapy. A dosedependent relationship. Ann Intern Med 114:128-132
4. Stoykov I (2006) Thyroid hormone receptors in the heart. Thesis, University of Amsterdam, The Netherlands
5. Sadow PM, Chassande O, Koo EK et al (2003) Regulation of expression of thyroid hormone receptor isoforms and coactivators in liver and heart by thyroid hormone. Mol Cell Endocrinol 203:65-75. doi:10.1016/S0303-7207(03)00122-9
6. Hodin RA, Lazar MA, Chin WW (1990) Differential and tissuespecific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J Clin Invest 85:101-105. doi:10.1172/JCI114398
7. Hartong R, Wang N, Kurokawa R et al (1994) Delineation of three different thyroid response elements in promoter of rat sarcoplasmic reticulum Ca++ ATPase gene: demonstration that retinoid X receptor binds 50 to thyroid hormone receptor in response element 1. J Biol Chem 269:13021-13029
8. Franklyn JA, Green NK, Gammage MD et al (1989) Regulation of α-and β-myosin heavy chain messenger RNAs in the myocardium by amiodarone and thyroid status. Clin Sci 76:463-467
9. Morkin E (1993) Regulation of myosin heavy chains in the heart. Circulation 87:1451-1460
10. Danzi S, Ojamaa K, Klein I (2003) Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am J Physiol Heart Circ Physiol 284:H 2255-H 2262
11. Kinugawa K, Yonekura K, Ribeiro RCJ et al (2001) Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89:591-598. doi:10.1161/hh1901.096706
12. Stoykov I, Van Beeren HC, Moorman AFM, Christoffels VM, Wiersinga WM, Bakker O (2007) Effect of amiodarone and dronedarone administration on thyroid hormone-dependent gene expression in different cardiac components. Eur J Endocrinol 156:695-702. doi:10.1530/EJE-07-0017
13. Pantos C, Mourouzis I, Saranters T et al (2005) Thyroid hormone receptors alpha 1 and beta 1 are downregulated in the postinfarcted rat heart: consequences on the response to ischaemicreperfusion. Basic Res Cardiol 100:422-432. doi:10.1007/s00395-005-0545-554
14. Kahaly GJ, Dillman WH (2005) Thyroid hormone action in the heart. Endocr Rev 26:704-728. doi:10.1210/er.2003-0033
15. Van Beeren HC, Bakker O, Wiersinga WM (1995) Desethylamiodarone is a competetive inhibitor of the binding of thyroid hormone to the thyroid hormone a1-receptor protein. Mol Cell Endocrinol 112:15-19. doi:10.1016/0303-7207(95) 03578-U
16. Bakker O, Van Beeren HC, Wiersinga WM (1994) Desethylamiodarone is a noncompetetive inhibitor of the binding of thyroid hormone to the thyroid hormone b1-receptor protein. Endocrinology 134:1665-1670. doi:10.1210/en.134.4. 1665
17. Van Beeren HC, Bakker O, Wiersinga WM (2000) Desethylamiodarone interferes with the binding of co-activator GRIP to the beta 1 thyroid hormone receptor. FEBS Lett 481:213-216. doi:10.1016/S0014-5793(00)01970-0
18. Bogazzi F, Bartalena L, Brogioni S et al (2001) Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level. Eur J Endocrinol 145:59-64. doi:10.1530/eje.0.1450059
19. Plomp TA, Wiersinga WM, Maes RA (1985) Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages. Arzneimittelforschung 35:1805-1810
20. Schröder-van der Elst JP, Van der Heide D (1990) Thyroxine, T3, and reverse T3 concentrations in several tissues of the rat: effects of amiodarone and desethylamiodarone on thyroid hormone metabolism. Endocrinology 127:1656-1664
21. Gotzsche LB, Orskov H (1994) Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo-and hyperthyroid rats. Eur J Endocrinol 130:281-290
22. Singh BN, Connolly SJ, Cryns HJ et al (2007) Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357:987-999. doi:10.1056/NEJMoa054686
23. Van Beeren HC, Jong WM, Kaptein E et al (2003) Dronedarone acts as a selective inhibitor of 3, 5, 30-triiodothyronine binding to thyroid hormone receptor-alpha 1: in vitro and in vivo evidence. Endocrinology 144:552-558. doi:10.1210/en.2002-220604
24. Pantos C, Mourouzis I, Malliopoulou V et al (2005) Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor a1. Thyroid 15:16-23. doi:10.1089/thy.2005.15.16
25. Shi R-q, Lee J-K, Hayashi Y et al (2007) Long term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile. Eur J Pharmacol 578:270-278. doi: 10.1016/j.ejphar.2007.09.039
26. Le Bouter S, Demolombe S, Chambellan A et al (2003) Microarray analysis altered thyroid status: relation to cellular and integrated electrophysiology. Circ Res 92:234-242. doi:10.1161/01.RES.0000053185.75505.8E
27. Le Bouter S, El Harchi A, Marionneau C et al (2004) Long-term amiodarone administration remodels expression of ion channels transcripts in the mouse heart. Circulation 110:3028-3035. doi: 10.1161/01.CIR.0000147187.78162.AC
28. Pantos C, Mourouzis I, Xinaris C et al (2008) Thyroid hormone and "cardiac metamorphosis": potential therapeutic implications. Pharmacol Ther 118:277-294. doi:10.1016/j.pharmthera.2008.02.011